Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. L. Hembruff
Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy Against Triple-Negative Human Breast Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Highly Effective Combination of LSD1 (KDM1A) Antagonist and Pan-Histone Deacetylase Inhibitor Against Human AML Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor Against Human Acute Myelogenous Leukemia Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Superior Activity of the Combination of Histone Deacetylase Inhibitor LAQ824 and the FLT-3 Kinase Inhibitor PKC412 Against Human Acute Myelogenous Leukemia Cells With Mutant FLT-3
Clinical Cancer Research
Cancer Research
Oncology
The Chk1 Inhibitor MK-8776 Increases the Radiosensitivity of Human Triple-Negative Breast Cancer by Inhibiting Autophagy
Acta Pharmacologica Sinica
Medicine
Pharmacology
A Chimeric SERM-Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Synergistic Effects of Combined Treatment With Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and TRAIL on Human Breast Cancer Cells
Scientific Reports
Multidisciplinary
Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells
Antioxidants and Redox Signaling
Cell Biology
Molecular Biology
Biochemistry
Clinical Biochemistry
Medicine
Physiology
A Novel Γ-Lactam-Based Histone Deacetylase Inhibitor Potently Inhibits the Growth of Human Breast and Renal Cancer Cells
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Combination of the Novel Histone Deacetylase Inhibitor YCW1 and Radiation Induces Autophagic Cell Death Through the Downregulation of BNIP3 in Triple-Negative Breast Cancer Cells in Vitro and in an Orthotopic Mouse Model
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine